Cite
HARVARD Citation
Yeoh, Z. et al. (2023). Venetoclax and hypomethylating agent therapy for accelerated and blast phase BCR::ABL negative myeloproliferative and extramedullary disease. Leukemia & lymphoma. 64 (4), pp. 757-760. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yeoh, Z. et al. (2023). Venetoclax and hypomethylating agent therapy for accelerated and blast phase BCR::ABL negative myeloproliferative and extramedullary disease. Leukemia & lymphoma. 64 (4), pp. 757-760. [Online].